Predictors of quality of life in people with Parkinson’s disease: evidence for both domain specific and general relationships

References

• Guyatt G, Feeny D, Patrick D. Measuring health-related quality of life. Ann Intern Med 1993;22:622–9
   Google Scholar
• Martinez-Martin P, Jeukens-Visser M, Lyons K, et al. Health-related quality-of-life scales in Parkinson's disease: critique and recommendations. Movement Disord 2011;26:2371–80
   PubMed Web of Science ®Google Scholar
• Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well-being for individuals with Parkinson's disease. Qual Life Res 1995;4:241–8
   PubMed Web of Science ®Google Scholar
• Huang T, Wang B, Chen K. Quality of life in parkinson's disease patients: validation of the short-form eight-item Parkinson's disease questionnaire (PDQ-8) in Taiwan. Qual Life Res 2011;20:499–505
   PubMed Web of Science ®Google Scholar
• Katsarou Z, Bostantjopoulou S, Peto V, et al. Quality of life in Parkinson's disease: Greek translation and validation of the Parkinson's disease questionnaire (PDQ-39). Qual Life Res 2001;10:159–63
   PubMed Web of Science ®Google Scholar
• Kwon D, Kim J, Ma H, et al. Translation and validation of the Korean version of the 39-item Parkinson's disease questionnaire. J Clin Neurol 2013;9:26–31
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Günther D. Effect of medical and surgical interventions on health-related quality of life in Parkinson's disease. Movement Disord 2007;22:757–65
   PubMed Web of Science ®Google Scholar
• Daniels C, Krack P, Volkmann J, et al. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable? Movement Disord 2011;26:2516–21
   PubMed Web of Science ®Google Scholar
• de Dreu M, van der Wilk A, Poppe E, et al. Rehabilitation, exercise therapy and music in patients with Parkinson's disease: a meta-analysis of the effects of music-based movement therapy on walking ability, balance and quality of life. Parkinson Relat Disord 2012;18:114–19
   PubMedGoogle Scholar
• Ehab G, Barsnley S, Chellappa R. Effect of physical exercise-movement strategies programme on mobility falls and quality of life in Parkinson's disease. Int J Therap Rehabil 2012;19:88–96
   Google Scholar
• Martinez-Martin P, Kurtis M. Systematic review of the effect of dopamine receptor agonists on patient health-related quality of life. Parkinson Relat Disord 2010;15:58–64
   Google Scholar
• Soh S-E, Morris M, McGinley J. Determinants of health-related quality of life in Parkinson’s disease: a systematic review. Parkinson Relat Disord 2011;17:1–9
   PubMed Web of Science ®Google Scholar
• Forjaz MJ, Frades-Payo B, Martinez-Martin P. The current state of the art concerning quality of life in Parkinson's disease: II. Determining and associated factors. Revista de Neurologia 2009;49:655–60
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri K. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Movement Disord 2011;26:399–406
   PubMed Web of Science ®Google Scholar
• Post B, Muslimovic D, van Geloven N, et al. Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease. Movement Disord 2011;26:449–56
   PubMed Web of Science ®Google Scholar
• Winter Y, von Campenhausen S, Popov G, et al. Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study. Parkinson Relat Disord 2010;16:243–8
   PubMed Web of Science ®Google Scholar
• Klepac N, Trkulja V, Relja M, Babić T. Is quality of life in non-demented Parkinson’s disease patients related to cognitive performance? A clinic-based cross-sectional study. Eur J Neurol: the Official Journal of the European Federation of Neurological Societies 2008;15:128–33
   PubMed Web of Science ®Google Scholar
• Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatr 2000;69:308–12
   PubMed Web of Science ®Google Scholar
• GPDSC. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Movement Disord 2002;17:60–7
   PubMed Web of Science ®Google Scholar
• Chapuis S, Ouchchane L, Metz O, et al. Impact of the motor complications of Parkinson’s disease on the quality of life. Movement Disord 2005;20:224–30
   PubMed Web of Science ®Google Scholar
• Ellis T, Cavanaugh J, Earhart G, et al. Which measures of physical function and motor impairment best infuence quality of life in Parkinson's disease? Parkinson Relat Disord 2011;17:693–7
   PubMed Web of Science ®Google Scholar
• Chrischilles E, Rubenstein L, Voelker M, et al. Linking clinical variables to health-related quality of life in Parkinson's disease. Parkinson Relat Disord 2002;8:199–209
   PubMed Web of Science ®Google Scholar
• Abudi S, Bar-Tal Y, Ziv L, Fish M. Parkinson's disease symptoms—‘patients’ perceptions. J Adv Nurs 1997;25:54–9
   PubMed Web of Science ®Google Scholar
• Hinnell C, Hurt C, Landau S, et al. Nonmotor versus motor symptoms: how much do they matter to health status in Parkinson's disease? Movement Disord 2012;27:236–41
   PubMed Web of Science ®Google Scholar
• Zhao Y, Tan L, Lau P, et al. Factors affecting health-related quality of life amongst Asian patients with Parkinson’s disease. Eur J Neurol: the Official Journal of the European Federation of Neurological Societies 2008;15:737–42
   PubMed Web of Science ®Google Scholar
• Leroi I, Ahearn D, Andrews M, et al. Behavioural disorders, disability and quality of life in Parkinson's disease. Age Ageing 2011;40:614–21
   PubMed Web of Science ®Google Scholar
• Robottom B, Gruber-Baldini A, Anderson K, et al. What determines resilience in patients with Parkinson's disease? Parkinson Relat Disord 2012;18:174–7
   PubMed Web of Science ®Google Scholar
• Soh S, McGinley J, Watts J, et al. Determinants of health-related quality of life in people with Parkinson's disease: a path analysis. Qual Life Res 2013;22:1543–53
   PubMed Web of Science ®Google Scholar
• Keeling M, Bamborough J, Simpson J. Depression, anxiety and positive affect in people diagnosed with low grade tumours: the role of illness perceptions. Psycho-Oncol 2013;22:1421–7
   PubMed Web of Science ®Google Scholar
• Rahman S, Griffin H, Quinn N, Jahanshahi M. On the nature of fear of falling in Parkinson’s disease. Behav Neurol 2011;24:219–28
   PubMed Web of Science ®Google Scholar
• Dubayova T, Nagyova I, Havlikova E, et al. The association of type D personality with quality of life in patients with Parkinson's disease. Aging Mental Health 2009;13:905–12
   PubMed Web of Science ®Google Scholar
• Scalzo P, Flores C, Marques J, et al. Impact of changes in balance and walking capacity on the quality of life in patients with Parkinson's disease. Arquivos de Neuro-Psiquiatria 2012;70:119–24
   PubMed Web of Science ®Google Scholar
• Hoehn M, Yahr M. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427–42
   PubMed Web of Science ®Google Scholar
• Karlsen K, Larsen J, Tandberg E, Maeland J. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatr 1999;66:431–43
   PubMed Web of Science ®Google Scholar
• Barak Y, Achiron A. Happiness and neurological disease. Exp Rev Neurotherapeut 2009;9:445–59
   PubMed Web of Science ®Google Scholar
• McCarthy B, Brown R. Psychosocial factors in Parkinson’s disease. Br J Clin Psychol 1989;28:41–52
   PubMed Web of Science ®Google Scholar
• Ridder D, Schreurs K, Bensing J. The relative benefits of being optimistic: optimism as a coping resource in multiple sclerosis and Parkinson’s disease. Br J Health Psychol 2000;5:141–55
   Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98
   PubMed Web of Science ®Google Scholar
• Dobson C. Conducting research with people not having the capacity to consent to participation; 2008. Available from: http://www.psy.ed.ac.uk/psy_research/documents/BPS%20Guidelines%20for%20Conducting%20Research%20with%20People%20not%20having%20Capacity%20to%20Consent.pdf [last accessed 24 Jan 2014].
   Google Scholar
• HMSO. Mental Capacity Act 2005. London: The Stationery Office; 2005
   Google Scholar
• Fahn S, Elton R. Unified Parkinson's disease rating scale. In: Fahn S, Marsden C, Goldstein M, Calne D, eds. Recent developments in Parkinson's disease. New Jersey: Macmillan Healthcare Information; 1987:153–63
   Google Scholar
• Hobson J, Edwards N, Meara R. The Parkinson's disease activities of daily living scale: a new simple and brief subjective measure of disability in Parkinson's disease. Clin Rehabil 2001;15:241–6
   PubMed Web of Science ®Google Scholar
• Lovibond S, Lovibond PF. Manual for the Depression Anxiety Stress Scales. Sydney: Psychology Foundation of Australia; 1996
   Google Scholar
• Crawford JR, Henry JD. The Depression Anxiety Stress Scales (DASS): normative data and latent structure in a large non-clinical sample. Br J Clin Psychol 2003;42:111–31
   PubMed Web of Science ®Google Scholar
• Simpson J, Haines K, Lekwuwa G, et al. Social support and psychological outcome in people with Parkinson's disease: evidence for a specific pattern of associations. Br J Clin Psychol 2006;45:585–90
   PubMed Web of Science ®Google Scholar
• Scheier MF, Carver CS. Effects of optimism on psychological and physical well-being: theoretical overview and empirical update. Cogn Therap Res 1992;16:201–28
   Web of Science ®Google Scholar
• Shifren K. Individual differences in the perception of optimism and disease severity: a study among individuals with Parkinson's disease. J Behav Med 1996;19:241–71
   PubMed Web of Science ®Google Scholar
• Rosenburg M. Society and the adolescent self-image. Princeton (NJ): Princeton University Press; 1965
   Google Scholar
• Schmitt DP, Allik J. Simultaneous administration of the Rosenberg Self-Esteem Scale in 53 nations: exploring the universal and culture-specific features of global self-esteem. J Person Soc Psychol 2005;89:623–42
   PubMed Web of Science ®Google Scholar
• Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Person Soc Psychol 1988;54:1063–70
   PubMed Web of Science ®Google Scholar
• Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The PDQ-8: development and validation of a short-form Parkinson's disease questionnaire. Psychol Health 1997;12:805–14
   Web of Science ®Google Scholar
• IBM Corp R. IBM SPSS Statistics for Windows, Version 19.0. Armonk (NY): IBM Corp.; 2010
   Google Scholar
• Brod M, Mendelsohn GA, Roberts B. Patients' experiences of Parkinson's disease. J Gerontol Series B: Psychol Sci Soc Sci 1998;53:213–22
   PubMed Web of Science ®Google Scholar
• Edgar K, Skinner T. Illness representations and coping as predictors of emotional well-being in adolescents with type 1 diabetes. J Pediatr Psychol 2003;28:485–93
   PubMed Web of Science ®Google Scholar
• Field A. Discovering statistics using SPSS, 3rd ed. London: Sage; 2010
   Google Scholar
• Wegelin J, McNamara P, Durso R, et al. Correlates of excessive daytime sleepiness in Parkinson's disease. Parkinson Relat Disord 2005;11:441–8
   PubMed Web of Science ®Google Scholar
• Simpson J, McMillan H, Reeve D. Reformulating psychological difficulties in people with Parkinson’s disease: the potential of a social relational approach to disablism. Parkinson's Dis 2013; 2013:608562. doi: 10.1155/2013/608562
   PubMedGoogle Scholar
• Hoops S, Nazem S, Siderowf A, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009;73:1738–45
   PubMed Web of Science ®Google Scholar
• Hagell P, Nygren C. The 39 item Parkinson’s disease questionnaire (PDQ-39) revisited: implications for evidence based medicine. J Neurol, Neurosurg Psychiatr 2007;78:1191–8
   PubMed Web of Science ®Google Scholar
• Weintraub D, Morales KH, Moberg PJ, et al. Antidepressant studies in Parkinson's disease: a review and meta-analysis. Movement Disord 2005;20:1161–9
   PubMed Web of Science ®Google Scholar
• Dobkin RD, Allen LA, Menza M. Cognitive-behavioral therapy for depression in Parkinson's disease: a pilot study. Movement Disord 2007;22:946–52
   PubMed Web of Science ®Google Scholar
• Marras C, McDermott MP, Rochon PA, et al. Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial. Movement Disord 2008;23:653–9
   PubMed Web of Science ®Google Scholar
• Oehlberg K, Barg FK, Brown GK, et al. Attitudes regarding the etiology and treatment of depression in Parkinson's disease: a qualitative study. J Geriatr Psychiatr Neurol 2008;21:123–32
   PubMed Web of Science ®Google Scholar
• Fitzpatrick L, Simpson J, Smith A. A qualitative analysis of mindfulness-based cognitive therapy (MBCT) in Parkinson's disease. Psychol Psychother: Theory Res Pract 2010;83:179–92
   PubMed Web of Science ®Google Scholar
• Charidimou A, Seamons J, Selai C, Schrag A. The role of cognitive-behavioural therapy for patients with depression in Parkinson's disease. Parkinson's Dis 2011;2011:Article ID 737523
   PubMedGoogle Scholar
• Dobkin RD, Menza M, Allen LA, et al. Cognitive behavior therapy for depression in Parkinson’s disease: a randomized controlled trial. Am J Psychiatr 2011;168:1066–74
   PubMed Web of Science ®Google Scholar
• Delaney M, Leroi I, Simpson J, Overton PG. Impulse control disorders in Parkinson’s disease: a psychosocial perspective. J Clin Psychol Med Settings 2012;19:338–46
   PubMed Web of Science ®Google Scholar